Detection of hepatitis A antibodies by ELISA using saliva as clinical samples

The possibility of detecting acute infection and immunity using body fluids that are easier to collect than blood, mainly in children, would facilitate the investigation and follow-up of outbreaks of hepatitis A (HAV). Our study was carried out to evaluate the detection of anti-HAV IgM, IgA and total antibodies in saliva using serum samples as reference. Forty three paired serum and saliva samples were analyzed. From this total, 24 samples were obtained from children and 1 from one adult during the course of acute hepatitis A; an additional 18 samples were obtained from health professionals from Adolfo Lutz Institute. The sensitivity to detect anti-HAV IgM was 100% (95%CI: 79.1 to 100.0%), employing saliva as clinical samples. In detecting anti-HAV IgA, the sensitivity was 80.8% (95%CI: 60.0 to 92.7%) and for the total antibodies was 82.1% (95%CI: 62.4 to 93.2%). The specificity was 100% for each. The rate of agreement was high comparing the results of serum and saliva samples for detecting HAV antibodies. We conclude that saliva is an acceptable alternative specimen for diagnosing acute hepatitis A infection, and for screening individuals to receive hepatitis A vaccine or immunoglobulin.

Saved in:
Bibliographic Details
Main Authors: OBA,Isabel Takano, SPINA,Angela Maria Miranda, SARACENI,Cláudia Patara, LEMOS,Marcílio Figueiredo, SENHORAS,Rita de Cássia Ferreira Andrade, MOREIRA,Regina Célia, GRANATO,Celso Francisco Hernandes
Format: Digital revista
Language:English
Published: Instituto de Medicina Tropical de São Paulo 2000
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0036-46652000000400004
Tags: Add Tag
No Tags, Be the first to tag this record!